ea0029p714 | Diabetes | ICEECE2012
Anil C.
, Demir C.
, Erismis B.
, Can S.
, Yalcin S.
, Altundag O.
, Gunes G.
, Bascil Tutuncu N.
Introduction: Despite the relation between Type 2 Diabetes Mellitus (DM) and development of malignancy is well known, data on antidiabetic drugs and cancer risk is contradictory. Thesis which have suggested that analogue insulins, especially glargine, increase cancer risk, has not been validated. The present study aimed to evaluate the possible contributions of diabetes durations and medications to the type and course of malignancy in patients with both diabetes and malignancy...